Introduction
tionally. Whether sputum can effectively be removed Cystic fibrosis (CF) is an autosomal recessive disease before gene transfer remains unclear. associated with premature death usually caused by perOther factors may also prejudice efficient gene transfer sistent pulmonary infection, bronchiectasis and respirunder these circumstances. Recombinant human deoxyatory failure. The identification of the gene mutated in ribonuclease (rhDNase), known to reduce sputum visco-CF and the characterisation of the protein for which it elasticity 8 and to improve lung function in both modercodes -the cystic fibrosis transmembrane conductance ately and severely affected patients 9 is now widely regulator (CFTR) 1-3 -have been swiftly followed by the prescribed for CF. rhDNase acts by cleaving neutrophildevelopment of strategies for treating the disease with derived DNA present in infected sputum. Its effect on gene therapy. A number of phase I clinical trials are exogenous DNA has not been studied but its presence already reported [4] [5] [6] [7] or underway, and all studies have in the airways represents a potentially adverse factor for focused on the respiratory tract as the target organ. While efficient gene transfer. This raises the question of whether delivery of gene therapy topically to the airways of CF patients receiving rhDNase would be required to stop patients is likely to be the most efficient route, it is also this treatment while receiving gene therapy or whether likely that in the presence of established lung disease, its advantageous mucolytic effects would weigh in favgene transfer to the respiratory epithelium will be our of rhDNase being a useful adjunct for more efficient impeded by the sputum lining CF airways. The sputum gene transfer. may not only present an impenetrable barrier to the gene In this study we have investigated the effect of freshly delivery system, limiting access to the underlying respirobtained CF sputum on the efficiency of gene transfer atory epithelial cells, but may also affect its integrity, in vitro by transferring the reporter gene ␤-galactosidase (pCMV␤) 10 complexed with either the cationic liposome DC-Chol/DOPE 11 or incorporated in an adenoviral vector (AdCMVNLS␤gal), 12 into epithelial cell lines main-improved following removal of the sputum, first by simpre-incubated with rhDNase (50 g/ml) ( Figure 2a ). Compared with PBS, however, there was no significant ply washing with phosphate-buffered saline (PBS) and then by incubation with various mucolytic agents, comimprovement following pre-incubation with N-acetylcysteine, Nacystelyn, lysine (each 20 mm) or with recomparing the effects of rhDNase with other mucolytics. Finally, we have studied gene transfer in the presence binant alginate lyase (0.5 U/ml). Similarly, transfer of ␤-galactosidase to the human bronchial epithelial cell line of exogenous genomic DNA to determine whether the inhibitory effect of CF sputum on gene transfer efficiency 16HBE14o−, (Figure 2b ) and to the CF submucosal epithelial cell line 2CFSMEo− (Figure 2c ) was markedly might be attributable to its high DNA content.
inhibited in the presence of sputum and not significantly improved following washing of the cells with PBS before
Results
gene transfer. Transfection efficiency was again significantly (P Ͻ 0.005) improved following washing of the The presence of sputum limits liposome-mediated gene cells with rhDNase but not with other mucolytic agents transfer efficiency in vitro and this effect is concentration before transfection. dependent In the presence of fresh sputum derived from CF patients and diluted 1:1 in OptiMEM, transfer of ␤-galactosidase complexed with the cationic liposome DC-Chol/DOPE (n = 6) to Cos 7 cells was markedly reduced compared with control cells transfected in the presence of OptiMEM alone ( Figure 1 , solid bars). This effect was concentration dependent. In the presence of sputum diluted 1:10, ␤-galactosidase transfer remained at a similar level to control but improved significantly (P Ͻ 0.005) by the time the sputum was diluted to 1:10 000. Even at this dilution, however, transfection efficiency did not reach control levels. Removal of the sputum from the cells by washing with PBS before gene transfer did not result in significant amelioration of this effect ( Figure 1 , open bars).
Removal of sputum with rhDNase but not with other mucolytic agents significantly improves gene transfer efficiency Compared with simple PBS washing of cells covered with sputum (diluted 1:10) before transfection, efficiency of gene transfer to Cos 7 cells was significantly (P Ͻ 0.005) improved when the sputum-covered cells were Figure 3 ).
The presence of sputum also limits the efficiency of adenovirus-mediated gene transfer in vitro and this effect is similarly abrogated by washing of the sputum with rhDNase Transfer of ␤-galactosidase complexed with the adenoviral vector AdCMVNLS to the three cell lines, Cos 7, 16HBEo− and 2CFSMEo−, was limited in the presence of fresh CF sputum, and again this effect was concentration dependent (Figure 4) . In all three cell lines, incubation of the sputum-covered cells with rhDNase (50 g/ml) before transfection significantly (P Ͼ 0.05) improved transfection efficiency compared with control cells transfected in the presence of sputum without rhDNase. In the case of the 16HBEo− cells, rhDNase treatment resulted in transfection efficiency that was significantly (P Ͼ 0.05) higher than that seen in control cells transfected in the absence of sputum.
Gene transfer efficiency in vitro is inhibited in the presence of exogenous genomic DNA. This effect is concentration dependent and ameliorated by incubation of the DNA-covered cells with rhDNase before transfection Transfection of Cos 7 cells in the presence of increasing concentrations of exogenous genomic DNA resulted in a concentration-dependent decline in transfection efficiency ( Figure 5 ). At the highest concentration used (500 g/ml), transfection efficiency was inhibited to less than 10% of control cells transfected in the absence of exogenous DNA. At a concentration of 1 g/ml, how- and produce large amounts of sputum, who are most likely to be the focus of clinical trials. Furthermore, they present the challenge of developing gene therapy not only to prevent lung disease but also to halt progression of established disease. It is therefore important to study the effects of sputum on gene transfer and to find ways of ameliorating these effects.
Mucus is known to act as a physical barrier by preventing passage of molecules Ͼ17 000 mol. wt. from reaching the epithelium. 13 The size of a DNA-liposome complex, even in its theoretically simplest conformation, is log orders greater than this ( ations, the effect of UV sterilization of the sputum before the gene transfer experiments should be noted. It was not possible to perform these experiments using fresh,
Discussion
infected CF sputum without prior sterilization because early contamination of the cell cultures prevented further In this study we have shown that the efficiency of both cationic liposome-mediated and adenovirus-mediated assessment of gene transfer. It is possible that exposure to UV light may destroy those components of sputum gene transfer to epithelial cells in vitro is markedly reduced in the presence of CF sputum and that this effect most likely to have adverse effects on gene transfer, for example, the high molecular weight components of spuis concentration related. Removal of the sputum from the cell monolayers by washing with PBS does not ameliorate tum or the alginates produced by colonizing mucoid Pseudomonas aeruginosa. 15, 16 Nevertheless, the fact that the the effect, suggesting that sputum not only presents a physical barrier but may bind to cell surface structures sterilized sputum used in these experiments limited gene transfer efficiency makes it likely that untreated sputum thereby limiting gene transfer. Removal of sputum with the mucolytic agent rhDNase, however, significantly may present an even greater barrier to gene transfer. Thus, this model may simulate a more optimum set of improves transfection efficiency suggesting that the high DNA content in CF sputum is likely to play an important conditions than would be met in vivo. Mucus glycoproteins are high molecular weight biorole in the inhibition of gene transfer efficiency. This possibility is strengthened by the demonstration that in polymers where glycopeptides are linked together by disulfide bonds. The macromolecule contains 80% sugar the presence of genomic DNA alone, transfection is inhibited in a concentration-related manner which can be residues and this allows the potential for hydrogen bonding between adjacent chains leading to the formation of reversed by pre-incubation of the DNA-covered cells with rhDNase. Finally, despite the potential for rhDNasea complex, three-dimensional viscoelastic gel. Agents such as N-acetylcysteine have the capacity to break disulinduced degradation of the transgene, plasmid DNA when complexed with either a cationic liposome or an fide bonds, whereas lysine will disrupt hydrogen (secondary) bonding. Both types of agents would be preadenoviral vector, retains functional integrity in the presence of rhDNase.
dicted to exert mucolytic activity and their combination as Nacystelyn has been shown to be synergistic in vitro.
17
Gene therapy for CF is likely to be most effective if undertaken before the onset of lung damage and the Since neither agent alone nor the combination (ie Nacystelyn) increased gene transfer in these experiments, chronic production of sputum. Nevertheless, in practice, the last few decades have witnessed a dramatic increase one conclusion is that the mucoglycoproteins in CF sputum, do not by themselves represent a significant barrier in the survival of patients with CF, attributable in large part to early diagnosis and intervention as well as to cell access by the gene and its delivery vehicle. Mucoid Pseudomonas aeruginosa, a common opportunadvances in antibiotic therapy and nutritional support. Thus, the median survival has increased to approxiistic pathogen in CF, produces large quantities of the exopolysaccharide alginate. Alginate is thought to premately 30 years and currently more than a third of CF patients are over the age of 16. These are the patients, serve the bacterial eco-environment by protecting the organism from dehydration. It is also thought to play a many of whom are colonised with Pseudomonas aeruginosa demonstrated above suggest that alginate is not primarily responsible for inhibition of gene transfer. However, it is These structures, studied by freeze-fracture electron microscopy, resemble 'meatball-spaghetti' assemblies possible that alginates may have been degraded during the UV sterilization of the sputum, masking their effects.
including liposome complexes ('meatballs') and bilayer lipid-covered DNA ('spaghetti') connected to liposome Alternatively, it has previously been shown that the action of alginate lyase on the viscoelastic properties of complexes as well as occurring free in suspension. With respect to transfection, there is some evidence to suggest CF sputum is limited 26 and this limitation has been attributed to inhibition of the enzyme by high levels of Zn 2+ that the lipid-coated spaghetti-like structures may be the active DNA-liposome complex. The DNA encapsulation and/or Ca 2+ present in CF sputum. Extracellular DNA released by disintegrating inflamby the bilayer coating may well provide some protection from degradation by rhDNase. Whether transfection matory cells, particularly neutrophils, is present in infected sputum in high concentrations. [27] [28] [29] The cloning efficiency in the presence of rhDNase could be further improved to control levels by increasing the amount of of the gene for human DNase I has been followed by the development of the recombinant human protein (dornase DNA-liposome complex delivered remains to be elucidated. alpha) and has been shown in vitro to reduce the viscoelasticity and adhesiveness of CF sputum. 8 rhDNase is In the case of adenovirus-mediated gene transfer, pretreatment of sputum-covered cells with rhDNase resulted administered by aerosol inhalation and has been evaluated extensively for safety and efficacy in patients with in recovery of gene transfer efficiency to within the control range. These data suggest that here, the limitation of CF у5 years with a baseline forced vital capacity у40% of predicted value. 9 Phase I, II and III clinical trials of gene transfer efficiency was essentially due to the sputum barrier and that the transgene within its viral carrier nebulised rhDNase have demonstrated improved lung function and a reduction in the incidence of respiratory remains fully protected from potential adverse effects of rhDNase. tract infectious exacerbations requiring parenteral antibiotics. 9 Consequently, it is now widely prescribed for In conclusion, we present an in vitro model for gene transfer across a sputum barrier in the lower airways of CF, involving Ͼ50% of adult patients and approximately 15% of children with CF at the Royal Brompton Hospital.
CF patients. Although this model cannot be directly comparable with in vivo gene transfer across a sputum barReversal of the inhibitory effect of CF sputum on gene transfer by rhDNase suggested that the high DNA conrier, the study demonstrates that purulent CF sputum has an adverse affect on gene transfer and that removal of tent of the sputum was likely to play an important role in inhibition. To confirm this hypothesis, transfection was the sputum may be a necessary prerequisite for gene therapy to the lower airways in patients with excess carrried out in the presence of increasing concentrations of exogenous DNA. In order optimally to simulate the mucus production. Finally, the study suggests that mucolytic treatment with rhDNase may be appropriate before components of CF sputum, genomic rather than plasmid DNA was used. The concentration range chosen was gene transfer into the airways, providing a useful adjunct to gene transfer efficiency regardless of whether cationic based on approximate measurements previously documented for CF sputum in vivo (approximately 0.6 liposomes or an adenoviral vector is used for gene delivery. mg/ml), 29 and took into account the 1:10 dilution of sputum used in the experiments described above. The inhibition of transfection demonstrable in the presence of
Materials and methods
genomic DNA proved similar to that seen when transfection was carried out in the presence of CF sputum and suggests that DNA plays an important role as a barrier Cells All media and supplements were obtained from Gibco to gene transfer in vivo.
By the nature of its action, we expected that concomi-BRL, Paisley, UK. The SV-transformed renal epithelial cell line Cos 7 (derived from African Green Monkey) 31 tant use of rhDNase with gene transfer agents would be contraindicated, raising the possibility that rhDNase was maintained at 37°C/5%CO 2 in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal would have to be withdrawn from CF patients enrolled for clinical trials of gene transfer. This study, however, bovine serum (FBS), 1% l-glutamine and 1% penicillin/streptomycin. The human bronchial epithelial demonstrates a beneficial effect of rhDNase upon gene transfer efficiency across a sputum barrier, albeit only cell line (16HBE14o−) 32 and the CF submucosal epithelial cell line (2CFSMEo−) 33 were maintained in minimum with partial restoration. The observations suggest, furthermore, that neutrophil-derived DNA may bind to epiessential medium (MEM) supplemented with 10% FBS, 1% penicillin/streptomycin, 1% l-glutamine and nonthelial cell surfaces in a manner that is not reversible by PBS washing and that it is this sputum component which essential amino acids.
Sputum per well), frozen at −70°C and thawed at room temperature. From each well 50 l of cell lysate was transferred Fresh sputa were obtained from CF patients (n = 6 for each set of experiments) admitted to the Royal Brompton to a 96-well plate and to each well was added 50 l PBS containing 0.5% BSA, 150 l chlorophenol red galactoHospital with an infective pulmonary exacerbation and who were known to be colonized with mucoid strains of pyranoside (1 mg/ml in a buffer containing 60 mm Na 2 HPO 4 , 1 mm MgSO 4 , 10 mm KCl and 50 mM ␤-Pseudomonas aeruginosa. The sputum was transferred to plastic Petri dishes (Greiner Labortechnik, Dursley, UK), mercaptoethanol). Following 60 min incubation at 37°C, the plate was read at 578 nm in a microtitre plate. sterilized by exposure to a short-wave UV light source for 30 min and then mixed with OptiMEM at ratios of Absorption readings were converted to pg of ␤-galactosidase using a standard curve of ␤-galactosidase. To min-1:1, 1:10, 1:100, 1:1000, 1:10000 and 1:100000 (v:v).
imize the effects of differing cell numbers and cell growth, the amount of ␤-galactosidase expression Plasmid DNA The eukaryotic expression plasmid pCMV␤ (Clontech obtained was standardized by calculation of the amount of protein present in each cell lysate. Protein was assayed Laboratories, Palo Alto, CA, USA) containing the Escherichia coli ␤-galactosidase gene under the control of the using the Bradford method 36 in a microassay protocol adapted for use in 96-well plates (Bio-Rad, Hemel cytomegalovirus immediate-early promoter and enhancer was used to assess transgene expression after Hempstead, UK) read at 595 nm. Absorption readings were converted to g protein using a bovine serum albucell transfection. Plasmid DNA was prepared as described previously. 34 min standard curve. Thus data are expressed as pg ␤-galactosidase/g protein.
Cationic liposomes DC-Chol was prepared using the method of Gao and
Removal of sputum with PBS and with mucolytic agents Cells were covered with sputum (diluted 1:10 Huang 11 and the cationic liposome DC-Chol/DOPE was prepared by microfluidisation and diluted to a final consputum:OptiMEM) and incubated at 37°C/5%CO 2 for 60 min. Sputum was then removed from each well by washcentration of 2 mol/ml (1.2 mg/ml total lipid).
ing three times with PBS. This was followed by the addition of 400 l OptiMEM per well and the transfection Adenovirus AdCMVNLS␤gal is an E1a/E3-deleted Ad5-based adenprocedure followed as described above. Alternatively, following washing with PBS, the cells were incubated for oviral vector containing the ␤-galactosidase gene under control of the CMV early promoter and enhancer.
a further 60 min in the presence of one of the following mucolytic agents N-acetylcysteine, lysine (both Sigma, AdCMVNLS␤gal infectious particles were prepared by standard methods as previously described. 12 Poole, Dorset, UK), Nacystelyn (Galephar SMB, Brussels, Belgium) (each 20 mm, pH 7.4), recombinant bacterial alginate lyase (0.5 enzyme units per well; a gift from P Cell transfection using cationic liposomes Cells were plated in 24-well tissue-culture grade plates Gacesa, Department of Applied Biology, University of Central Lancashire, UK) and rhDNase (50 g/ml) (Greiner Labortechnik) at 1 × 10 5 per well and maintained at 37°C/5% CO 2 until 60-70% confluent in their respect-(Pulmozyme; Genentech, Welwyn Garden City, UK). Of these agents, only N-acetylcysteine and rhDNase are in ive growth media. Cells were washed with PBS (pH 7.4) and the medium replaced with either 400 l of OptiMEM clinical use. In the case of the former the concentration chosen was the highest shown not to be cytotoxic to epi-(positive control) or the equivalent volume of sputum diluted in OptiMEM at the ratios described above. The thelial cells in culture. 37 In the case of the latter, the concentration chosen reflects the concentration used in vivo, DNA and liposomes were complexed by mixing of the two components at a ratio of 1:5 weight/weight DNA:libased on the daily nebulised dose of 2.5 mg reaching the conducting airways with a surface area of approximately posome, and immediately added to the cells (5 g DNA per well). Media or media/sputum mixtures were 60 cm 2 . 38 All the agents were removed by washing with PBS, replaced with OptiMEM and the cells transfected as removed 18-24 h after transfection, the cells were washed twice with PBS and the media replaced with the approdescribed above. priate normal growth media.
Determination of the effect of rhDNase on the functional efficiency of the gene-liposome complex Cell transfection using adenovirus Cells were grown as described above. Before transfection, Cos 7 cells were plated as described above. The transfection procedure was similarly carried out as above, but cells were washed with PBS and 400 l of MEM or the equivalent volume of sputum diluted in MEM at the in the presence of increasing concentrations of rhDNase, added to each well at the same time as the addition of ratios described above were added. AdCMVNLS␤gal (10 l containing 6.5 × 10 5 p.f.u./l) was added to each well the DNA-liposome complexes. Thus, the following amounts of rhDNase were added: 0.5 g/ml, 5 g/ml, to give an estimated MOI of 6.5. Media or media/sputum mixtures were removed after 2 h and replaced with the 50 g/ml, 100 g/ml and 500 g/ml. appropriate normal growth media for each cell line.
Preparation of genomic DNA from rat lung As previously described, 39 1.5 g of rat lung were incu-␤-Galactosidase assay The cells were assayed for ␤-galactosidase activity using bated in 9 ml proteinase K buffer (100 mm NaCl, 100 mm EDTA, 50 mm Tris-HCl, pH 8, 1% SDS, 6 mg/ml proteina photometric assay previously described. 35 Briefly, 36 or 48 h after transfection using cationic liposomes or adenase K (Gibco BRL, Life Technologies, Paisley, UK) ) overnight at 55°C. Following two extractions with phenol: ovirus respectively, the cells were lysed in a solution containing 0.1% Triton X-100 and 250 mm Tris (pH 8, 350 l chloroform:isoamyl alcohol (25:24:1, Gibco BRL, Life further analysis. The data are presented as mean ± s.e.m. 
